TITLE

Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe

AUTHOR(S)
van der Straten, Ariane; Helen Cheng; Minnis, Alexandra M.
PUB. DATE
January 2010
SOURCE
Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: We examined the use of male condoms and the diaphragm following completion of a clinical trial of the diaphragm's HIV prevention effectiveness. In the trial, called Methods for Improving Reproductive Health in Africa (MIRA), women were randomized to a diaphragm group (diaphragm, gel and condoms) or a condom-only control group. At trial exit, all women were offered the diaphragm and condoms. Methods: Our sample consisted of 801 Zimbabwean MIRA participants who completed one post-trial visit (median lapse: nine months; range two to 20 months). We assessed condom, diaphragm and any barrier method use at last sex act at enrolment, final MIRA and post-trial visits. We used multivariable random effects logistic regression to examine changes in method use between these three time points. Results and discussion: In the condom group, condom use decreased from 86% at the final trial visit to 67% post trial (AOR = 0.20; 95% CI: 0.12 to 0.33). In the diaphragm group, condom use was 61% at the final trial visit, and did not decrease significantly post trial (AOR = 0.77; 95% CI: 0.55 to 1.09), while diaphragm use decreased from 79% to 50% post trial (AOR = 0.18; 95% CI: 0.12 to 0.28). Condom use significantly decreased between the enrolment and post-trial visits in both groups. Use of any barrier method was similar in both groups: it significantly decreased between the final trial and the post-trial visits, but did not change between enrolment and the post-trial visits. Conclusions: High condom use levels achieved during the trial were not sustained post trial in the condom group. Post-trial diaphragm use remained relatively high in the diaphragm group (given its unknown effectiveness), but was very low in the condom group. Introducing "new" methods for HIV prevention may require time and user skills before they get adopted. Our findings underscore the potential benefit of providing a mix of methods to women as it may encourage more protected acts.
ACCESSION #
64933588

 

Related Articles

  • Gel-safe.  // Echo Magazine;11/4/2004, Vol. 16 Issue 4, p52 

    Reports on the commencement of clinical trials for an anti-HIV gel treatment through a partnership between GlaxoSmithKline PLC and the nonprofit International Partnership for Microbicides in November 2004. Status of the clinical trials for vaginal microbicides; Challenges faced by medical...

  • Acceptability Research on Female-Controlled Barrier Methods to Prevent Heterosexual Transmission of HIV: Where Have We Been? Where Are We Going? Elias, Christopher; Coggins, Christiana // Journal of Women's Health & Gender-Based Medicine;Mar2001, Vol. 10 Issue 2, p163 

    Acceptability research is an important component of any product development process. As researchers move into a new, accelerated phase of vaginal microbicide development, it is important to take stock of the acceptability research conducted to date and determine future research priorities. In...

  • TREATMENT OF LATE-STAGE HIV INFECTION. Millard, Peter S. // Journal of Family Practice;Feb1997, Vol. 44 Issue 2, p132 

    The article discusses research being done on the effectiveness of zidovudine given alone or in combination with didanosine or zalcitabine to HIV-infected patients in preventing AIDS-defining events or death. It references a study by L. D. Saravolatz et al published in a 1996 issue of the "New...

  • Halt to microbicide trial sets back AIDS research. Moszynski, Peter // BMJ: British Medical Journal (International Edition);2/10/2007, Vol. 334 Issue 7588, p276 

    The author reports that two phase III clinical trials of a topical microbicide gel, cellulose sulfate, in testing for prevention of HIV in women have been stopped due to preliminary results that demonstrated an increased risk of HIV infection. Separate phase III trials of three other...

  • Trials Planned to Confirm Efficacy of Tenofovir Microbicide Gel. McEnery, Regina // VAX;Nov2010, Vol. 8 Issue 6, p3 

    The article reports on the plan to conduct two confirmatory trials on the efficacy of Tenofovir Microbicide Gel in preventing HIV infections, which will involve 3,000 women in South Africa.

  • NEW COMBINATION STUDIED.  // AIDS Patient Care & STDs;Mar2000, Vol. 14 Issue 3, p169 

    Reports that the AIDS Research Alliance in Los Angeles, California, is recruiting subjects for a small phase I/II trial of an antiretroviral combination. Investigation of the anti-malaria drug hydroxychloroquine; Antiviral activity exhibited by the drug.

  • Establishing ethical trials for treatment and prevention of AIDS in developing countries. Lo, Bernard; Bayer, Ronald // BMJ: British Medical Journal (International Edition);8/9/2003, Vol. 327 Issue 7410, p337 

    Developing countries have been hardest hit by HIV but often cannot afford the expensive drugs or high tech health care used in Western countries. How can researchers and sponsors of trials investigating treatment and prevention of HIV in developing countries make sure they take proper account of...

  • Late-Phase Diaphragmatic Hernia: A Case Report. İçme, Ferhat; Balkan, Erkan; Becel, Sinan; Şener, Alp; Kurtoğlu, Gülhan Çelik; Avcı, Akkan // Journal of Academic Emergency Medicine Case Reports / Akademik A;2013, Vol. 4 Issue 4, p170 

    Diaphragmatic rupture (DR) is a well-known complication of blunt or penetrating injuries that affect the diaphragm, but it may be easily overlooked when it is not taken into consideration or when physical examination findings and radiographs are not evaluated carefully. We present a patient...

  • Understanding the Effects of Hormonal Contraception on HIV Transmission. McEnery, Regina // VAX;Nov2011, Vol. 9 Issue 6, p4 

    The article reports on the risks and benefits of using hormonal contraception in HIV prevention trials. It indicates that the mechanism of how hormonal contraception increased the risk of HIV infection is not clear. It suggests the importance of identifying the mechanisms that accelerate or...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics